Výsledky vyhledávání - "Nikeshia Dunkelly-Allen"

Ranibizumab: A Review of Its Use in the Treatment of Diabetic Retinopathy in Patients With Diabetic Macular Edema

Autor: Nikeshia Dunkelly-Allen, Oluwaranti Akiyode

Publikováno v: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians. 32(1)

Objective: To evaluate the pharmacotherapy role of ranibizumab, a vascular endothelial growth factor (VEGF) inhibitor, for the treatment of diabetic retinopathy (DR) in patients with diabetic macular edema (DME). Data Sources: PubMed, Science Direct,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd55cb5cb2718d3c3ca57784a12a4dae
https://pubmed.ncbi.nlm.nih.gov/34860956

Zobrazit plný text záznamu

An assessment of the relationship between pharmacy students’ perceptions of their preparedness to contribute to emergency responses and their current work status

Autor: Salome Bwayo Weaver, Jateh Major, Nikeshia Dunkelly-Allen, Kevin Nguyen, La’Marcus T. Wingate

Publikováno v: Currents in Pharmacy Teaching and Learning. 10:1579-1586

Introduction A study was conducted to assess if there is an association between pharmacy students’ perceptions of their preparedness to contribute to emergency responses and their current work status. Methods A cross-sectional analysis was conducte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::983898476aedfa1b39b84eea237f10fc
https://doi.org/10.1016/j.cptl.2018.09.005

Zobrazit plný text záznamu

Real-World Effectiveness and Safety of Field- and Lesion-Directed Treatments for Actinic Keratosis

Autor: Steven R. Feldman, Nikeshia Dunkelly-Allen, Karen A Veverka, Thomas Larsson, Jes B Hansen

Publikováno v: Journal of drugs in dermatology : JDD. 19(8)

Background: Real-world data for actinic keratosis treatment in the United States is lacking. Objectives: To understand real-world treatment patterns for actinic keratosis by type and modality, and compare effectiveness and safety of therapies, either

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c8be4db118e2ea8ce328fe64084412c
https://pubmed.ncbi.nlm.nih.gov/32804451

Zobrazit plný text záznamu

16258 Evaluation of different approaches in managing local skin reactions with the use of ingenol mebutate 0.015% and 0.05% during the treatment of actinic keratosis

Autor: Miriam S. Bettencourt, Karen A Veverka, Meg Corliss, Nikeshia Dunkelly-Allen, Scott R. Freeman

Publikováno v: Journal of the American Academy of Dermatology. 83:AB58

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3ae04d78b759f26799652c690b8977af
https://doi.org/10.1016/j.jaad.2020.06.320

Zobrazit plný text záznamu

16127 Efficacy of ingenol mebutate in patients with actinic keratosis on face and scalp: Subgroup analysis of a 12-month observational follow-up study according to age (<65 and ≥65 years)

Autor: Jes B Hansen, Hee Jin Kim, Karen A Veverka, Nikeshia Dunkelly-Allen, Mark Lebwohl

Publikováno v: Journal of the American Academy of Dermatology. 83:AB172

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::993c4ee8e479fcc1e672e074c9c4cf97
https://doi.org/10.1016/j.jaad.2020.06.775

Zobrazit plný text záznamu

Evaluation of Different Approaches in Managing Local Skin Reactions With the Use of Ingenol Mebutate 0.015% and 0.05% During the Treatment of Actinic Keratosis

Autor: Meg Corliss, Karen A Veverka, Nikeshia Dunkelly-Allen, Scott R. Freeman, Miriam S. Bettencourt

Publikováno v: SKIN The Journal of Cutaneous Medicine. 4:s65

not available.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b734addd5b2921e87965a9057789a96
https://doi.org/10.25251/skin.4.supp.64

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání